[144] Nexxen International Ltd. SEC Filing

Rhea-AI Filing Summary

Nexxen International Ltd. (NEXN) filed a Form 144 disclosing a proposed sale of 73,067 ordinary shares through Oppenheimer & Co. with an aggregate market value of $681,715.11, with an approximate sale date of 08/15/2025 on Nasdaq. The filer acquired the securities as restricted stock units on 02/25/2020, with two RSU grants shown totaling 263,200 shares acquired on that date. The filing also reports insider sales during May 2025 totaling 124,542 shares for gross proceeds of $3,714,113.94. Outstanding shares are reported as 65,562,670, allowing readers to gauge the relative size of the transactions.

Positive

• Planned sale clearly disclosed with broker, share count, value and expected sale date
• Acquisition history provided showing RSU grants dated 02/25/2020 totaling 263,200 shares
• Prior sales in May 2025 fully reported with dates, amounts and gross proceeds totaling $3,714,113.94

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider sales disclosed but represent a small percentage of outstanding shares; monitor for pattern of continued disposals.

The filing documents a planned sale of 73,067 shares valued at $681,715.11 and prior May 2025 dispositions totaling 124,542 shares for $3,714,113.94. Relative to 65,562,670 shares outstanding, these sales are immaterial on a percentage basis (~0.19% for May sales, ~0.11% for the proposed sale). The shares originated from RSU grants dated 02/25/2020, indicating these are previously granted equity awards being liquidated. From a financial standpoint, the transactions provide liquidity to the insider but do not, by themselves, imply material dilution or financing events for the company.

Corporate Governance Expert

TL;DR: Disclosure adheres to Rule 144 format; documentation of RSU origin and prior sales supports regulatory compliance.

The Form 144 lists the broker, planned sale date, share counts, acquisition dates and nature of acquisition (Restricted Stock Units), fulfilling customary disclosure elements. The signer affirms no undisclosed material adverse information. The record of multiple sales in May 2025 plus the upcoming August sale warrants routine governance attention to insider trading policies and blackout windows, but the filing itself contains the expected information and signatures to demonstrate compliance with Rule 144 procedures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	73067	681715.11	65562670	08/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	02/25/2020	Restricted Stock Units	Issuer			150000	02/25/2020	N/A
Ordinary	02/25/2020	Restricted Stock Units	Issuer			113200	02/25/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Niri Sagi 82 YIGAL ALON STREET TEL AVIV L3 6789124	Ordinary	05/15/2025	64052	3032170.44
Niri Sagi 82 YIGAL ALON STREET TEL AVIV L3 6789124	Ordinary	05/16/2025	1223	14202.94
Niri Sagi 82 YIGAL ALON STREET TEL AVIV L3 6789124	Ordinary	05/19/2025	36411	410592.28
Niri Sagi 82 YIGAL ALON STREET TEL AVIV L3 6789124	Ordinary	05/20/2025	22856	257148.28

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Nexxen (NEXN) disclose in this Form 144?

The filer disclosed a proposed sale of 73,067 ordinary shares valued at $681,715.11, with an approximate sale date of 08/15/2025 on Nasdaq.

How many shares were sold by the insider during May 2025?

124,542 shares were sold across four transactions in May 2025 for gross proceeds of $3,714,113.94.

What is the origin of the shares to be sold?

The shares were acquired as Restricted Stock Units (RSUs) on 02/25/2020, with two entries totaling 263,200 shares acquired that day.

Who is the broker handling the proposed sale?

Oppenheimer & Co. Inc., 85 Broad St. New York NY 10004 is listed as the broker for the transaction.

How large are the proposed and prior sales relative to outstanding shares?

Outstanding shares: 65,562,670; the May 2025 sales (~124,542 shares) represent ~0.19% of outstanding shares and the proposed 73,067-share sale is ~0.11%.